Injections for macular degeneration (anti-VEGF)
Regular injections into the eye that aim to control wet age-related macular degeneration and protect central vision, usually needing repeat treatment over a long period.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- Anti-VEGF injections control wet AMD and protect central vision, but they are usually an ongoing treatment, not a cure.
- Most people need loading injections then repeat injections for months or years; stopping too soon can let vision worsen.
- Treatment often stabilises vision and can improve it, but it cannot reverse damage that has already happened.
- Serious eye infection (endophthalmitis) is rare but an emergency — a painful, red eye with worsening vision after an injection needs urgent care.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Can stop wet AMD from getting worse in many people
Dry AMD does not respond to anti-VEGF injections, which are for the wet (neovascular) type.
The eye may feel gritty, watery or mildly sore and vision can be blurry. Avoid rubbing the eye and do not drive until your vision is clear.
Clear, written warning signs of infection and an urgent same-day contact route.
The eye may feel gritty, watery or mildly sore and vision can be blurry. Avoid rubbing the eye and do not drive...
Any red patch on the white of the eye and grittiness usually settle. Watch for increasing pain, redness or...
After loading injections the specialist checks, often with a scan, whether the leakage is settling and how your...
Repeat injections continue on a schedule guided by scans, with the gaps sometimes lengthened if the disease stays...

What are anti-VEGF injections for macular degeneration?
Wet age-related macular degeneration (wet AMD) is when abnormal blood vessels grow under the centre of the retina (the macula) and leak fluid or blood, quickly blurring or distorting central vision.
Anti-VEGF medicines are injected into the jelly of the eye to block the signal that drives these abnormal vessels. This dries up the leakage, often stabilising vision and sometimes improving it. UK medicines include ranibizumab, aflibercept, faricimab and, used off-label, bevacizumab.
The most important thing to understand is that this is usually an ongoing treatment, not a one-off cure. Most people start with several injections close together (loading doses) and then continue with repeat injections, often for years, to keep the disease controlled. If injections stop too soon, vision can get worse again. The injections are generally well tolerated, and a serious eye infection (endophthalmitis) is rare but important to recognise quickly.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
How anti-VEGF treatment is usually given
| Phase | What happens | Why |
|---|---|---|
| Loading | Several injections close together | To get the disease under control quickly |
| Maintenance | Repeat injections, often every 4–8+ weeks | To keep leakage controlled |
| Monitoring | Regular scans (OCT) of the macula | To time injections and catch flare-ups |
Schedules vary by medicine and by how your eye responds. Your specialist will explain your plan and how long treatment may continue.
Preparing for your injection
- Understand that this is usually a long-term course of repeat injections, not a single treatment.
- Arrange not to drive home, as your vision may be blurred and the eye uncomfortable for a short time.
- Tell the team about any eye infections, recent eye surgery, or allergies before each injection.
- Mention if you are on blood thinners, though injections are usually still possible.
- Plan for regular visits and scans over months to years, and how you will get to them.
- Ask which medicine you will have, how often, and how the gaps between injections will be decided.
What happens
The injection is done as an outpatient in a clean treatment room. The eye is numbed with anaesthetic drops or gel, the surface is cleaned with an antiseptic, and a small clip gently holds the eyelids open.
The specialist injects a tiny amount of medicine through the white of the eye, to the side, so you do not see the needle coming. It usually feels like brief pressure rather than pain and takes only a minute or two. You may notice floaters, a small red patch on the white of the eye, or mild grittiness afterwards. The eye is checked and you are given advice before you go home.
Is this injection right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- Dry AMD does not respond to anti-VEGF injections, which are for the wet (neovascular) type.
- An eye with advanced scarring at the macula may gain little from injections.
- An active eye infection means an injection must be delayed.
- Some people cannot commit to the frequent visits needed, which should be discussed honestly.
Delay or rearrange if…
- There is an active infection in or around the eye.
- You have recently had eye surgery that needs to settle first.
- You are unwell with a condition that makes a sterile procedure unsafe for now.
- Important scans confirming active disease are still awaited.
Alternatives to discuss
- Watchful monitoring for dry AMD or inactive disease, with home vision checks.
- A different anti-VEGF medicine or schedule if one is not working or not tolerated.
- Photodynamic therapy in selected, unusual cases where offered.
- Low-vision support, magnifiers and registration for sight impairment to maintain independence.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Comfort, sedation or contrast choices
If local anaesthetic, sedation, contrast or pain relief is used, ask what is planned, why, and what it means afterwards.
Benefits
- Can stop wet AMD from getting worse in many people
- Can improve central vision in some people, especially when started early
- Reduces leakage of fluid and blood at the macula
- Done as a quick outpatient treatment without a hospital stay
- Helps protect the ability to read, recognise faces and stay independent
Risks & complications
- A red patch on the white of the eye where the needle went in
- Gritty, sore or watery eye for a day or so
- Floaters or seeing the medicine move in your vision briefly
- Needing repeat injections over a long period
- A short-lived rise in pressure inside the eye
- Bruising or irritation from the eyelid clip and antiseptic
- A small bleed under the surface of the eye that looks dramatic but settles
- Reduced response over time, needing a change of medicine or schedule
- Serious infection inside the eye (endophthalmitis), which can threaten sight
- Injury to the lens (cataract) or a retinal tear or detachment from the needle
- Inflammation inside the eye, or a small risk of stroke or heart attack discussed with your specialist
Two things matter most. First, this is usually a long-term commitment: missing injections can let the disease become active again and damage vision. Second, although a serious eye infection (endophthalmitis) is rare, it is an emergency — an increasingly painful, red eye with worsening vision in the days after an injection needs urgent assessment. Ask your specialist how often you will need injections, how long treatment may continue, and exactly what to do if your eye becomes painful afterwards.
Published figures to discuss
How much vision is gained or kept depends on how early treatment starts, how the disease behaves and how regularly injections are given. Serious complications are rare per injection, but the risk adds up over a long course, so safe technique and prompt recognition of infection matter.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| Serious infection inside the eye (endophthalmitis) | Rare — around 0.05% per injection (roughly 1 in 2,000) in large series; a pooled estimate of about 0.056% | An emergency; a painful, red eye with worsening vision after an injection needs urgent care. | Endophthalmitis rates among anti-VEGF patients: claims analysis — PMCpmc.ncbi.nlm.nih.govPublished figure |
| Short-lived raised pressure inside the eye | Common immediately after injection but usually short-lived; persistent pressure rise is much less common | Monitored at appointments, especially over a long course of injections. | Endophthalmitis rates among anti-VEGF patients: claims analysis — PMCpmc.ncbi.nlm.nih.govSource-linked context |
| Retinal tear or detachment from the injection | Rare, generally well below 1 in 1,000 injections in large series | Why new floaters, flashes or a shadow after an injection should be reported promptly. | Endophthalmitis rates among anti-VEGF patients: claims analysis — PMCpmc.ncbi.nlm.nih.govPublished figure |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
There is no real physical recovery from a single injection, but your eye may be gritty and red for a day or so, and your vision can be blurry briefly, so you should not drive straight afterwards. The bigger picture is the ongoing course of treatment and monitoring.
- A red patch on the white of the eye that fades over days
- Gritty, watery or mildly sore eye for a day or so
- Floaters or seeing the medicine move briefly after the injection
- Blurry vision for a short time after treatment
- Knowing you will return for more injections and scans
Aftercare
- Do not rub the eye, and avoid swimming and dusty environments for a day or two.
- Use any drops you are given as directed, and do not drive until your vision is clear.
- Watch closely for increasing pain, redness or worsening vision in the days after an injection.
- Attend all injection and monitoring appointments, even if the eye feels fine.
- Use an Amsler grid or check each eye separately at home if advised, to spot changes.
- Keep a record of which eye and which medicine you receive at each visit.
- Know the urgent contact route for signs of infection.
- A lift home arranged (no driving after the injection)
- Any prescribed drops collected
- Amsler grid or home vision check set up if advised
- Injection and scan appointments noted
- List of medicines and allergies ready for the team
- Emergency eye contact number saved
Scars and how they heal
There is no skin scar. The needle passes through the white of the eye and often leaves a small red patch (like a bruise on the eye surface) that clears over days. There is no external mark.
⚠ Get urgent help if…
- Increasing eye pain in the days after an injection
- Worsening redness and the eye becoming very sensitive to light
- Worsening or sudden loss of vision after an injection
- Increasing floaters, flashes or a shadow or curtain in your vision
- Discharge from the eye or feeling generally unwell with eye symptoms
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A good result is that the leakage at the macula dries up and your central vision stabilises, and sometimes improves, particularly if treatment is started early. The benefit is judged over the first months using your vision and scans of the macula.
Injections cannot reverse scarring or damage that has already happened, and the disease can become active again if treatment stops or stretches too far apart. Your specialist should be clear that the aim is long-term control of the disease, not a one-off cure.
Anti-VEGF treatment controls wet AMD rather than curing it, so the benefit lasts as long as the disease stays suppressed. Many people need injections for years, with the gaps adjusted to how the eye responds. The other eye is also at risk over time, so both eyes are monitored.
Related tests, treatments or support
Anti-VEGF injections are sometimes combined with other treatments depending on the cause of the leakage. The same injections are also used for other conditions such as diabetic macular oedema and retinal vein problems, and laser or surgery may occasionally be added. Your specialist will explain what is right for you.
Follow-up & long-term care
You will be followed up regularly, usually with scans of the macula, to decide when the next injection is needed and whether the gaps can be lengthened. Report any increasing pain, redness or sudden vision change between appointments straight away.
- Repeat injections on a schedule guided by scans, often for years
- Regular OCT scans and vision checks to time treatment
- Home monitoring of each eye (for example with an Amsler grid) if advised
- Monitoring of the other eye for new wet AMD
- Prompt review of any sudden distortion or central blur
Repeat, follow-on and what comes next
- This is an ongoing treatment: repeat injections are the norm, often for years.
- The medicine or schedule may be changed if the response fades or the eye does not tolerate it.
- The gaps between injections are adjusted up or down based on scans.
- The second eye may later need its own course of injections.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- Clear, written warning signs of infection and an urgent same-day contact route.
- A defined injection and monitoring schedule, with scans to guide it.
- Honest discussion of how long treatment may continue and how progress is measured.
- Monitoring of both eyes and support such as low-vision services if vision is affected.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- Which anti-VEGF medicine is used and its cost
- Number of injections, including loading doses and ongoing maintenance
- Specialist (ophthalmologist) fee and treatment-room or facility fee
- Regular OCT scans and monitoring visits
- How long treatment continues, which is often years
- Whether the second eye also needs treatment
- The cost per injection, including the medicine and the procedure
- The likely number of injections over the first year
- Scan (OCT) and monitoring visit costs
- Whether a course or only single injections are quoted
- What ongoing treatment is likely to cost over time
- What happens, and what it costs, if a complication such as infection occurs
On the NHS? Anti-VEGF injections for wet AMD are commonly available on the NHS when the eye meets treatment criteria; private care is used mainly for speed of starting treatment or choice of provider.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Being led to expect a one-off cure rather than an ongoing course of injections.
- Not being warned that stopping injections can let vision worsen again.
- No clear, written plan for what to do if the eye becomes painful or red afterwards.
- Not discussing the time, travel and cost burden of long-term monitoring and treatment.
Marketing red flags
- Describing the injection as a pain-free or without risks quick fix.
- Promising restored vision or a permanent cure.
- Not mentioning that treatment is usually long-term.
- Downplaying the rare but serious risk of eye infection.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- Which medicine will I have, and why is it the right choice for me?
- How often will I need injections, and how long might treatment continue?
- How will you decide when to lengthen the gaps between injections?
- What exactly should I do if my eye becomes painful or red after an injection?
- How will you monitor my other eye?
- What happens to my vision if I have to miss injections?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my injection, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this injection not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
How often will I need injections?
Is this a cure?
Does the injection hurt?
What is the most serious risk?
Can I drive after the injection?
Are these injections available on the NHS?
Find a verified specialist for injections for macular degeneration (anti-vegf)
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: Macular Society — Wet age-related macular degeneration Macular Society — Macular disease treatments NICE — Ranibizumab and pegaptanib for wet AMD (TA155) Royal College of Ophthalmologists — patient information Incidence of endophthalmitis after anti-VEGF injection — Scientific Reports Endophthalmitis rates among anti-VEGF patients: claims analysis — PMC
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Laser treatment for diabetic retinopathy · Macular hole surgery · Vitrectomy · Cataract surgery · Corneal cross-linking (for keratoconus)